L. Orning et al., A PEPTIDE SEQUENCE FROM MOUSE-TISSUE FACTOR INHIBITS HUMAN TISSUE FACTOR-DEPENDENT FACTOR-X ACTIVATION, Thrombosis research, 92(3), 1998, pp. 135-140
Synthetic peptides based on the putative factor X recognition site of
human (Thr-Leu-Tyr-Tyr-Trp-Lys-Ser-Ser-Ser-Ser), rabbit (Thr-Leu-Tyr-T
yr-Trp-Arg-Ala-Ser-Ser-Thr), and murine tissue factor (Ile-Ile-Thr-Tyr
-Arg-Lys-Gly-Ser-Ser-Thr) were dose-dependent inhibitors of human tiss
ue factor/factor VIIa catalyzed factor X activation with IC50 values o
f 220, 17, and 33 mu M, respectively. The mouse results were highly su
rprising given the low homology between the human and mouse sequence (
40 %) and that mouse tissue factor, in contrast with rabbit tissue fac
tor, does not support the procoagulant activity of human factor VIIa o
n factor X. The inhibitory mechanism of the murine peptide was noncomp
etitive with respect to factor X but competitive with respect to tissu
e factor, indicating the peptide competes with tissue factor (or the t
issue factor/factor VIIa complex) for binding to factor X. The peptide
could be N-terminally truncated by two Ile without loss of inhibitory
activity or changed inhibitory mechanism. Substitution of two Gly for
the two Ile, which increased solubility, decreased IC50 to 17 mu M wh
ereas scrambling the peptide made it inactive. (C) 1998 Elsevier Scien
ce Ltd.